Rupestonic acid derivative YZH-106 inhibits the replication of influenza virus through up-regulating HO-1.
HO-1 induces the expression of type I IFNs possibly independent of its enzymatic activities.
HO-1 might be a promising host target for antiviral therapeutics against influenza and other viral infectious diseases.